13F
中

ETON ETON PHARMACEUTICALS INC

2026Q1 · CUSIP 29772L108 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
115
Δ holders QoQ
+11
Breadth percentile
Top 27%
Whale holders
57
Δ whales
+1
Inst. holding value
$435M
New positions
30
Closed positions
19
Price momentum (1Q)
+89.4%
Put / Call
3/3

Breadth history (34 quarters)

2019Q1: Δ+0 · h=13 2019Q2: Δ-2 · h=11 2019Q3: Δ+4 · h=15 2019Q4: Δ+1 · h=16 2020Q1: Δ+2 · h=18 2020Q2: Δ+24 · h=42 2020Q3: Δ-2 · h=40 2020Q4: Δ+8 · h=48 2021Q1: Δ+3 · h=51 2021Q2: Δ-4 · h=47 2021Q3: Δ-9 · h=38 2021Q4: Δ-6 · h=32 2022Q1: Δ-2 · h=30 2022Q2: Δ-1 · h=29 2022Q3: Δ+3 · h=32 2022Q4: Δ+0 · h=32 2023Q1: Δ+4 · h=36 2023Q2: Δ-2 · h=34 2023Q3: Δ+17 · h=51 2023Q4: Δ+6 · h=57 2024Q1: Δ-12 · h=45 2024Q2: Δ+1 · h=46 2024Q3: Δ+3 · h=49 2024Q4: Δ+23 · h=72 2025Q1: Δ+15 · h=87 2025Q2: Δ+0 · h=87 2025Q3: Δ+16 · h=103 2025Q4: Δ+1 · h=104 2026Q1: Δ+11 · h=115 2019Q1: holders=13 2019Q2: holders=11 2019Q3: holders=15 2019Q4: holders=16 2020Q1: holders=18 2020Q2: holders=42 2020Q3: holders=40 2020Q4: holders=48 2021Q1: holders=51 2021Q2: holders=47 2021Q3: holders=38 2021Q4: holders=32 2022Q1: holders=30 2022Q2: holders=29 2022Q3: holders=32 2022Q4: holders=32 2023Q1: holders=36 2023Q2: holders=34 2023Q3: holders=51 2023Q4: holders=57 2024Q1: holders=45 2024Q2: holders=46 2024Q3: holders=49 2024Q4: holders=72 2025Q1: holders=87 2025Q2: holders=87 2025Q3: holders=103 2025Q4: holders=104 2026Q1: holders=115 -24 -12 +0 +12 +24 965121 19Q119Q420Q321Q222Q122Q423Q324Q225Q125Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 3 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q1 Top 16% -17.2% -11.8%
2023Q3 Top 10% — —
2020Q2 Top 14% — —

Options Sentiment

Put holders
3
QoQ: +3
Call holders
3
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-0.06
EPS YoY
—
Revenue (TTM)
$0.1B
Revenue YoY
+79.9%
Quarterly Revenue & EPS (4Y)
2022-06-30: $7M 2022-09-30: $3M 2022-12-31: $8M 2023-03-31: $5M 2023-06-30: $12M 2023-09-30: $7M 2023-12-31: $7M 2024-03-31: $8M 2024-06-30: $9M 2024-09-30: $10M 2024-12-31: $12M 2025-03-31: $17M 2025-06-30: $19M 2025-09-30: $22M 2025-12-31: $21M 2026-03-31: $24M 2024-09-30: EPS 0.02 2024-12-31: EPS -0.02 2025-03-31: EPS -0.06 2025-06-30: EPS -0.10 2025-09-30: EPS -0.07 2025-12-31: EPS 0.06 2026-03-31: EPS 0.05 0M 12M 24M $M -0.11 -0.02 0.07 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)